October 15, 2013

Endologix Appoints David H. Deaton, MD, as Chief Medical Officer

October 15, 2013—Endologix (Irvine, CA) announced that it has appointed David H. Deaton, MD, to the newly created position of Chief Medical Officer, effective immediately.

Before joining Endologix, Dr. Deaton served as Chief of the Division of Vascular and Endovascular Surgery at MedStar Georgetown University Hospital and was Associate Professor of Surgery at Georgetown University in Washington, DC. Also at Georgetown, he was Director, Clinical Vascular Research, and Founder and Medical Director, Vascular Non-Invasive Laboratory.

John McDermott, President and Chief Executive Officer of Endologix, commented in the company's press release, “We are very pleased to welcome Dr. Deaton to the Endologix leadership team. He is a thought-leading vascular surgeon and pioneer in the endovascular treatment of abdominal aortic aneurysms. His clinical experience and perspective will be instrumental in our new product development programs and clinical studies. Dr. Deaton has been involved in the development and evolution of endovascular aortic therapy for 20 years and provided testimony to the US Food and Drug Administration that resulted in the first approved endovascular aortic repair device in the United States in 1999. Having Dr. Deaton join Endologix is an important step in our organizational growth and underscores our commitment to the healthcare community and patients with aortic disorders.”

Dr. Deaton commented, “Endologix has been an innovator in the treatment of aortic disease for the past several years. I have watched the company grow and been impressed with their focus and dedication to new treatments for aortic disease. I look forward to joining the Endologix leadership team and playing an active role in the development, clinical evaluation, and introduction of new technologies to advance the treatment of endovascular aortic repair.”

In addition to his roles at Georgetown, Dr. Deaton's previous experience includes similar clinical and academic positions at leading hospitals and academic centers in the United States. Dr. Deaton is a Fellow of the American College of Surgeons and a member of several vascular professional societies. He has served as an advisor in the development of many medical devices and is the author of numerous peer-reviewed publications and educational chapters.

Dr. Deaton received a BA in Chemistry from Haverford College and an MD from Duke University School of Medicine. He completed his surgical residency at the Hospital of the University of Pennsylvania. He completed a vascular fellowship at UCLA.


October 15, 2013

Oscor Introduces the Destino Twist Steerable Guiding Sheath

October 11, 2013

Bard Presents Rigorous Design of the LEVANT 2 Study for the Lutonix Drug-Coated Balloon